These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. Chen Y; Park YB; Patel E; Silverman GJ J Immunol; 2009 May; 182(10):6031-43. PubMed ID: 19414754 [TBL] [Abstract][Full Text] [Related]
3. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms. Rahman M; Sing S; Golabkesh Z; Fiskesund R; Gustafsson T; Jogestrand T; Frostegård AG; Hafström I; Liu A; Frostegård J Clin Immunol; 2016 May; 166-167():27-37. PubMed ID: 27102765 [TBL] [Abstract][Full Text] [Related]
4. Modulation of natural IgM autoantibodies to oxidative stress-related neo-epitopes on apoptotic cells in newborns of mothers with anti-Ro autoimmunity. Grönwall C; Clancy RM; Getu L; Lloyd KA; Siegel DL; Reed JH; Buyon JP; Silverman GJ J Autoimmun; 2016 Sep; 73():30-41. PubMed ID: 27289167 [TBL] [Abstract][Full Text] [Related]
5. Association between dietary and metabolic factors and IgM antibodies to phosphorylcholine and malondialdehyde in patients with systemic lupus erythematosus and population-based matched controls. Lourdudoss C; Ajeganova S; Frostegård J Clin Exp Rheumatol; 2018; 36(3):428-433. PubMed ID: 29745894 [TBL] [Abstract][Full Text] [Related]
6. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. Chou MY; Fogelstrand L; Hartvigsen K; Hansen LF; Woelkers D; Shaw PX; Choi J; Perkmann T; Bäckhed F; Miller YI; Hörkkö S; Corr M; Witztum JL; Binder CJ J Clin Invest; 2009 May; 119(5):1335-49. PubMed ID: 19363291 [TBL] [Abstract][Full Text] [Related]
7. Naturally occurring IgM antibodies to oxidation-specific epitopes. Binder CJ Adv Exp Med Biol; 2012; 750():2-13. PubMed ID: 22903662 [TBL] [Abstract][Full Text] [Related]
8. Natural antibodies to oxidation-specific epitopes: innate immune response and venous thromboembolic disease. Eichinger S; Kyrle PA; Kammer M; Eischer L; Ozsvar Kozma M; Binder CJ J Thromb Haemost; 2018 Jan; 16(1):31-35. PubMed ID: 29045005 [TBL] [Abstract][Full Text] [Related]
9. Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses. Kim SJ; Gershov D; Ma X; Brot N; Elkon KB Ann N Y Acad Sci; 2003 Apr; 987():68-78. PubMed ID: 12727625 [TBL] [Abstract][Full Text] [Related]
10. Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins. Damoiseaux J; Jeyasekharan AD; Theunissen R; Tervaert JW Ann N Y Acad Sci; 2005 Jun; 1050():163-9. PubMed ID: 16014530 [TBL] [Abstract][Full Text] [Related]
11. IgM antibodies against apoptotic cells and phosphorylcholine in patients with acute myocardial infarction in relation to infarct size and inflammatory response. Diepenhorst GM; Ciurana CL; Diaz Padilla N; Boekholdt SM; Krijnen PA; Lagrand WK; Niessen HW; Hack CE Adv Clin Exp Med; 2012; 21(4):455-67. PubMed ID: 23240451 [TBL] [Abstract][Full Text] [Related]
12. IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE. Grönwall C; Akhter E; Oh C; Burlingame RW; Petri M; Silverman GJ Clin Immunol; 2012 Mar; 142(3):390-8. PubMed ID: 22297166 [TBL] [Abstract][Full Text] [Related]
13. Antibodies against Phosphorylcholine and Malondialdehyde during the First Two Years of Life. Thiagarajan D; Lundström SL; Pershagen G; Almqvist C; Andolf E; Hedman A; Berg O; Oparina N; Frostegård J J Immunol; 2020 Oct; 205(8):2109-2116. PubMed ID: 32887753 [TBL] [Abstract][Full Text] [Related]
14. Natural antibodies against phosphorylcholine in cardiovascular disease. de Faire U; Frostegård J Ann N Y Acad Sci; 2009 Sep; 1173():292-300. PubMed ID: 19758165 [TBL] [Abstract][Full Text] [Related]
15. IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases. Thiagarajan D; Oparina N; Lundström S; Zubarev R; Sun J; ; Alarcon-Riquelme M; Frostegård J Sci Rep; 2020 Jul; 10(1):11010. PubMed ID: 32620913 [TBL] [Abstract][Full Text] [Related]
16. Naturally occurring human phosphorylcholine antibodies are predominantly products of affinity-matured B cells in the adult. Fiskesund R; Steen J; Amara K; Murray F; Szwajda A; Liu A; Douagi I; Malmström V; Frostegård J J Immunol; 2014 May; 192(10):4551-9. PubMed ID: 24729615 [TBL] [Abstract][Full Text] [Related]
17. Naturally occurring antibodies directed against carbohydrate tumor antigens. Schwartz-Albiez R Adv Exp Med Biol; 2012; 750():27-43. PubMed ID: 22903664 [TBL] [Abstract][Full Text] [Related]
18. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. Kim SJ; Gershov D; Ma X; Brot N; Elkon KB J Exp Med; 2002 Sep; 196(5):655-65. PubMed ID: 12208880 [TBL] [Abstract][Full Text] [Related]
19. Levels of natural IgM antibodies against phosphorylcholine in healthy individuals and in patients undergoing isolated limb perfusion. Padilla ND; Ciurana C; van Oers J; Ogilvie AC; Hack CE J Immunol Methods; 2004 Oct; 293(1-2):1-11. PubMed ID: 15541272 [TBL] [Abstract][Full Text] [Related]
20. The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases. Karsten CM; Köhl J Immunobiology; 2012 Nov; 217(11):1067-79. PubMed ID: 22964232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]